LifeVantage President and CEO Steve Fife announced “Rise ERA” as the company’s theme for 2024, encouraging attendees to rise above by imagining future possibilities and focusing on the basics to get there. 

“The launch of LV360 in 2023 helped to catalyze the foundational elements of our strategic transformation, laying the groundwork for long-term success,” Fife said. “This year is our year to ‘Rise’ from that foundation by focusing on the three fundamental keys to consultant success: Enrolling, Retaining, and (Rank) Advancing. It’s our ‘Rise ERA’–this calendar year will be the year we complete our international LV360 rollout and drive growth by simplifying everything to deliver on these three behaviors.” 

The new Rise ERA incentive unveiled available lifestyle and business prizes that increase in value as different “tracks” are achieved, which the company hopes will enhance goal setting and incremental behaviors. In addition, the company announced a February launch for LV360 Phase 2 in Mexico, Canada and Europe. 

“As LifeVantage begins our Rise ERA, we invite all consultants to embrace the focus and seize the opportunities that 2024 holds,” Fife said. “The corporate team is excited for everything in the works and confident that the focus on enrolling, retaining and advancing will deliver a year of growth and achievement.” 

The post LifeVantage Hosts Annual Global Kickoff Event  first appeared on Direct Selling News.

Net income per diluted shares remained unchanged from the prior year’s period at $0.05, while adjusted EBITDA increased 41.4% to $4 million. 

“We are very pleased with our first quarter results, which further demonstrate the effectiveness of LV360 in driving growth and profitability,” said Steve Fife, LifeVantage President and Chief Executive Officer. “Revenue in the U.S. was up 6.5%, reflecting continued strength in key products, including a 40% year-over-year increase in sales of TrueScience Liquid Collagen. Adjusted EBITDA increased by 41% to $4 million and our Adjusted EBITDA margin improved by 230 basis points versus a year earlier. Our passionate base of independent consultants continues to lean into the LV360 toolset, including the Evolve compensation plan and the Rewards Circle loyalty program, to grow their businesses by leveraging the power of LifeVantage’s unique position around activating wellness. Innovation should continue to provide a significant tailwind to our business as we recently introduced TrueScience TrueRenew Daily Firming Complex and are launching TrueScience Liquid Collagen in Mexico, the Philippines, and Canada in the second fiscal quarter. We remain confident in the direction and trajectory of our business and steadfast in our commitment to driving shareholder value.”    

Cash and cash equivalents at the end of the quarter totaled $18.4 million, down from $21.6 million on June 30, 2023, with no outstanding debt.  

Fiscal 2024 guidance now includes revenue between $216-$226 million with an adjusted EBITDA in the range of $16-$18 million. 

The post LifeVantage Fiscal Q1 2024 Revenue Reaches $51.4 Million  first appeared on Direct Selling News.

“Our Global Convention is always an inspiring time for the entire LifeVantage family,” said Steve Fife, LifeVantage President and CEO. “The partnership we have between the corporate office and our Consultants is second to none and our Global Convention always solidifies that relationship. It’s exciting to come together and go ‘all in’ on what we know will drive our business forward.” 

The company also debuted the next phase of its strategic transformation LV360. The new Evolve Compensation Plan will now include a Fast Track Reset Incentive to invite consultants to focus on the future, 90-days at a time, and enjoy bonuses typically only available to new consultants. 

“Earlier this year we began the roll-out of our LV360 transformation initiative, which also includes a new customer loyalty program, Rewards Circle, business tool enhancements, and the launches of new, innovative, scientifically backed products, among others,” Fife said. “We knew the evolution would be popular, but we never anticipated the wild success and energy surrounding this company transformation. It is palpable. We are moving into 2024 with unmatched advancements and a team whose momentum and determination appears unstoppable.” 

The post LifeVantage 2023 Convention Unveils Next Phase of LV360  first appeared on Direct Selling News.

Total active accounts saw a decline of 8.3% in the quarter to 143,000, with majority of that decline happening in the Asia/Pacific and Europe region. Adjusted EBITDA was $4.8 million, compared to $1.7 million in the previous year. 

For the full fiscal year 2023, revenue reached $213.4 million, a 3.4% increase over 2022, with an adjusted EBITDA of $11.7 million, down from $12.8 million in fiscal 2022. The United States proved to be one of the company’s strongest markets, with revenue increasing 13.4%, while the Asia/Pacific and Europe region saw a 14.7% decrease in revenue. 

“We had another strong quarter as the key strategic initiatives that underlie our LV360 transformation continue to gain traction and drive momentum across our business,” said Steve Fife, Life Vantage President and Chief Executive Officer. “Revenue exceeded guidance, profitability showed significant improvement and we again delivered high-teens growth in the U.S., reflecting the ongoing strength of new product offerings, including TrueScience® Liquid Collagen. Consultant engagement remains high driven by our Evolve compensation plan coupled with the benefits of Rewards Circle, our unique customer loyalty program, which are helping to amplify our brand messaging around Activating Wellness. Entering fiscal 2024, we are in a position of considerable strength with $21 million of cash, no debt, and profitability expected to show material improvement as we continue to grow the top line and execute on the core principles of LV360. The $0.40 per share special dividend we announced today along with the recent resumption of stock repurchase activity reflects our confidence in the future and underscores our long-standing commitment to enhancing shareholder value.” 

The post LifeVantage Reports Revenue of $54.2 Million in Fiscal Q4 2023  first appeared on Direct Selling News.

This invitation follows LifeVantage’s unveiling of its new Evolve Compensation Plan, a strategic component of the LV360 initiative, which includes a new customer loyalty program, Rewards Circle, business tool enhancements and the rollout of new products. 

“The entire LifeVantage team has worked incredibly hard over the past eighteen months to make LV360 a reality,” Fife said. “This invitation to showcase our achievements before a global audience by ringing the closing bell at Nasdaq further validates the direction we are headed. This revolutionary transformation, designed with the opportunity, growth, and success of our consultants in mind, has been well-received and is setting the new standard for the direct sales industry.” 

The post LifeVantage Invited to Ring Nasdaq Closing Bell  first appeared on Direct Selling News.

Net income per diluted share was $0.08, compared to $0.12 in the year ago period, with an adjusted EBITDA of $3.3 million, compared to $3.4 million in last year’s quarter. Cash generated was down from $5.2 million to $3.1 million during the first nine months of fiscal 2023. 

“Third quarter results demonstrate significant early progress of our LV360 strategic transformation initiatives, including our new Evolve compensation plan,” said Steve Fife, LifeVantage President and Chief Executive Officer. “Accelerating revenue growth was the most notable improvement of the quarter as we continued to see strong results from key products, led by TrueScience Liquid Collagen, which has been in the U.S. market since June 2022 and just launched this quarter in Australia, New Zealand, and Japan. On a constant currency basis, our third quarter revenue increased 10.4% including an 18.2% increase in the Americas. Evolve has been well received and is just starting to gain traction with our highly engaged base of consultants in the markets where it has launched. We remain confident in the trajectory of our business and are in in a strong position to deliver meaningful improvement in growth and profitability over the next several years.” 

The company ended the quarter with $19.5 million in cash and cash equivalents and no debt. Fiscal year 2023 guidance now includes revenue ranging between $209 million to $212 million with an adjusted EBITDA of $11 million to $13 million. 

The post LifeVantage Reports $53.7 Million in Revenue in Fiscal Q3 2023  first appeared on Direct Selling News.

This overall bump in revenue happened in spite of an 8.6% decline in total active accounts from last year, with the largest decline (12%) taking place in the Asia/Pacific and Europe regions. Revenue in this region was also down by 20.2%. 

The company’s adjusted EBITDA was $0.8 million, compared to $1.9 million a year ago and net loss per diluted share was $0.08, in contrast to last year’s net income of $0.01 per diluted share. 

“We reached a positive inflection point in the second quarter, delivering year-over-year revenue growth of 7.4% on a constant currency basis including a 15.4% increase in the U.S.,” said Steve Fife, LifeVantage President and Chief Executive Officer. “Our latest results reflect strong execution against our key priorities along with the continuation of robust sales from our innovative Liquid Collagen product that launched in June. LV360, the strategic transformation we recently announced, will help us build on this momentum by strengthening the alignment between consultants and customers with a new compensation plan and customer loyalty program that will go live on March 1st. Coupled with our strong innovation pipeline, including three new products launching concurrently, along with our expanding international distribution across core products and markets, our LV360 strategy solidifies our leadership as an activation company and positions us for growth and improved profitability.” 

The company rounded out the quarter with a strong balance sheet of $17.4 million in cash and no debt. 

The post LifeVantage Posts Revenue of $53.7 Million in Q2 of Fiscal 2023  first appeared on Direct Selling News.

During its Rock the Rhythm event that was simulcast to over 10,000 people, LifeVantage Corporation announced Evolve, a new consultant compensation plan and customer loyalty program that the company describes as “a modern approach to the evolving direct sales industry.” 

“We call this strategic transformation ‘LV360’ because we looked at not just one aspect of our consultant and customer experience, but every touchpoint in our model,” said Steve Fife, President and Chief Executive Officer of LifeVantage. “We have been laying the groundwork for this shift over the past year with updates to things like our incentive program as well as product differentiation and positioning. Each element of this groundbreaking transformation was designed in response to evolving consumer trends, while also supporting growth opportunities and multiple paths to earned success for our consultants, previously known as our distributors. It’s truly an undertaking that is the first of its kind in this industry.” 

The post LifeVantage Announces New Comp Plan as Part of LV360 Strategy first appeared on Direct Selling News.

Gross profit during the quarter was $41.8 million, or 80.8% of revenue, a marginal decline from 82.3% of revenue for the same period in fiscal 2022. The company attributes this decrease to elevated shipping costs, inflation and shifts in its geographic and product sales mix. 

Adjusted EBITDA was $2.8 million, compared to $5.8 million for the same period last year. 

“Results in the first quarter demonstrated continued momentum across our strategic initiatives around innovation and engagement,” said Steve Fife, President and Chief Executive Officer of LifeVantage. “The number of active independent distributors was up 1.6% on a year-over-year basis driven by an 18% increase in Asia/Pacific & Europe and revenue versus the prior year period was up 2.3% on a constant currency basis. Sales of the new Collagen product we launched in June far exceeded our initial expectations and the recent expansion of our flagship product Protandim NAD to Japan, Australia and New Zealand should help to propel growth in these key markets. At our global convention in October, energy levels remained very high and sharper messaging around our core focus on optimizing health and evolving possibilities continues to resonate well with distributors. Profitability is also poised to improve as we recently implemented a price increase that will serve to alleviate margin pressures stemming from inflationary factors. While the macroeconomic environment remains challenging, we are off to a solid start in fiscal 2023, making steady progress on transforming LifeVantage into a more dynamic, customer-centric organization that delivers consistent, sustainable growth and increases value for shareholders.” 

The company ended the quarter with a strong balance sheet of $17.6 million of cash and no debt.

The post LifeVantage Revenue Dips Slightly to $51.8 Million in Q1 of Fiscal 2023  first appeared on Direct Selling News.

The Asia/Pacific and Europe markets actually saw a 0.7% increase in revenue during the quarter, while the Americas declined by 10.5%. Total active accounts declined 10.9% in the Americas and 2% in the Asia/Pacific and Europe markets during this time. Adjusted EBITDA during the quarter was also down to $1.7 million, compared to $6.6 million last year. 

For the full fiscal 2022-year, revenue was down 6.3% to $206.4 million with adjusted EBITDA of $12.8 million, down from $24.8 million last year.  

“Fourth quarter results were in line with our expectations and we are very pleased with early progress on key initiatives around innovation and driving engagement across our base of customers and independent distributors,” said Steve Fife, LifeVantage President and Chief Executive Officer. “Revenue was up 2% sequentially to $51 million despite $1.3 million of negative FX impact and we delivered 100 basis points of sequential improvement in gross margin. We are seeing a strong response to our new collagen product, which launched in June in conjunction with Activate 2022, our recent distributor meeting in Salt Lake City. Momentum also continues to build in our Asia/Pacific and Europe region, where revenue increased 4% sequentially compared to the third quarter aided by an 8% increase in active independent distributors, in part reflecting a strong response to our recent Philippines launch. Entering fiscal 2023, our team is highly energized and we are well positioned to continue our customer-centric transformation by leveraging our powerful innovation platform as well as optimizing marketing through expanded adoption and capability enhancements to our proprietary digital tools.” 

The company ended the year with a strong balance sheet of $20.2 million in cash and cash equivalents with no outstanding debt. 

The post LifeVantage Reports Revenue of $206.4 Million in Fiscal 2022  first appeared on Direct Selling News.